These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32593276)

  • 21. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
    Zhang X; Ji L; Yang L; Tang X; Qin W
    Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A; Hada R; Agrawal RK; Bhattarai GR; Baral A
    BMC Nephrol; 2018 Jul; 19(1):175. PubMed ID: 29996800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
    Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS
    Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
    Rovin BH; Furie R; Latinis K; Looney RJ; Fervenza FC; Sanchez-Guerrero J; Maciuca R; Zhang D; Garg JP; Brunetta P; Appel G;
    Arthritis Rheum; 2012 Apr; 64(4):1215-26. PubMed ID: 22231479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
    Navaneethan SD; Viswanathan G; Strippoli GF
    Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
    Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis.
    Zhou T; Zhang X; Lin W; Lin S
    J Pharm Pharm Sci; 2019; 22(1):365-375. PubMed ID: 31580800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose rituximab in refractory lupus nephritis.
    Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
    Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey EM; Abdou SH; Shareef MM
    Clin Exp Nephrol; 2010 Jun; 14(3):214-21. PubMed ID: 20169461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
    Condon MB; Ashby D; Pepper RJ; Cook HT; Levy JB; Griffith M; Cairns TD; Lightstone L
    Ann Rheum Dis; 2013 Aug; 72(8):1280-6. PubMed ID: 23740227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis.
    Tian M; Song X; Dong L; Xin X; Dong J
    Medicine (Baltimore); 2017 Dec; 96(51):e9408. PubMed ID: 29390559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials.
    Palmer SC; Tunnicliffe DJ; Singh-Grewal D; Mavridis D; Tonelli M; Johnson DW; Craig JC; Tong A; Strippoli GFM
    Am J Kidney Dis; 2017 Sep; 70(3):324-336. PubMed ID: 28233655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis.
    Touma Z; Gladman DD; Urowitz MB; Beyene J; Uleryk EM; Shah PS
    J Rheumatol; 2011 Jan; 38(1):69-78. PubMed ID: 20952473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
    Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
    Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.
    Laskari K; Mavragani CP; Tzioufas AG; Moutsopoulos HM
    Arthritis Res Ther; 2010; 12(6):R208. PubMed ID: 21059275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of treatment response and serious infection using tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis.
    Song GG; Lee YH
    Int J Clin Pharmacol Ther; 2020 Oct; 58(10):550-556. PubMed ID: 32691727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.